全文获取类型
收费全文 | 56868篇 |
免费 | 5093篇 |
国内免费 | 1935篇 |
专业分类
耳鼻咽喉 | 650篇 |
儿科学 | 983篇 |
妇产科学 | 623篇 |
基础医学 | 11339篇 |
口腔科学 | 957篇 |
临床医学 | 3571篇 |
内科学 | 8786篇 |
皮肤病学 | 1254篇 |
神经病学 | 4153篇 |
特种医学 | 920篇 |
外国民族医学 | 16篇 |
外科学 | 4415篇 |
综合类 | 6628篇 |
现状与发展 | 9篇 |
预防医学 | 2223篇 |
眼科学 | 662篇 |
药学 | 9507篇 |
2篇 | |
中国医学 | 2310篇 |
肿瘤学 | 4888篇 |
出版年
2024年 | 130篇 |
2023年 | 1057篇 |
2022年 | 2052篇 |
2021年 | 2427篇 |
2020年 | 1921篇 |
2019年 | 2277篇 |
2018年 | 2364篇 |
2017年 | 2290篇 |
2016年 | 1981篇 |
2015年 | 2327篇 |
2014年 | 3314篇 |
2013年 | 3918篇 |
2012年 | 3384篇 |
2011年 | 4039篇 |
2010年 | 3148篇 |
2009年 | 3128篇 |
2008年 | 2881篇 |
2007年 | 2618篇 |
2006年 | 2321篇 |
2005年 | 1906篇 |
2004年 | 1795篇 |
2003年 | 1492篇 |
2002年 | 1132篇 |
2001年 | 866篇 |
2000年 | 845篇 |
1999年 | 698篇 |
1998年 | 686篇 |
1997年 | 663篇 |
1996年 | 544篇 |
1995年 | 581篇 |
1994年 | 486篇 |
1993年 | 416篇 |
1992年 | 348篇 |
1991年 | 328篇 |
1990年 | 290篇 |
1989年 | 242篇 |
1988年 | 186篇 |
1987年 | 188篇 |
1986年 | 192篇 |
1985年 | 345篇 |
1984年 | 407篇 |
1983年 | 248篇 |
1982年 | 283篇 |
1981年 | 227篇 |
1980年 | 200篇 |
1979年 | 157篇 |
1978年 | 113篇 |
1977年 | 111篇 |
1976年 | 127篇 |
1975年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
931.
Mano M Arakawa T Mano H Nakagawa M Kaneda T Kaneko H Yamada T Miyata K Kiyomura H Kumegawa M Hakeda Y 《Calcified tissue international》2000,67(1):85-92
Prostaglandins (PGs) are well known to be important local factors in regulating bone formation and resorption. PGE2 is a potent stimulator of bone resorption because of enhancing osteoclast formation by its indirect action through stromal
cells. However, the direct action of PGE2 on functionally mature osteoclasts is still controversial. In this study using highly purified rabbit mature osteoclasts,
we examined the direct effect of PGE2 on osteoclastic bone-resorbing activity and its mechanism. PGE2 inhibited resorption pit formation on a dentine slice by the purified osteoclasts in a dose- and time-dependent manner. The
inhibitory effect appeared as early as 4 hours after the PGE2 addition. Forskolin and 12-0-tetradecanoyl phorbol-13-acetate (TPA), respective activators of adenylate cyclase and protein
kinase C, also decreased the osteoclastic bone-resorbing activity. PGE2 increased the content of intracellular cAMP in a dose range effective for the inhibition of bone resorption, whereas the
prostanoid did not alter the intracellular level of inositol triphosphate. The inhibition of osteoclastic bone resorption
by PGE2 was amplified and diminished by a cAMP phosphodiesterase inhibitor (isobutyl methylxanthine) and a protein kinase A inhibitor
(Rp-cAMP), respectively. Of four different subtypes of PGE2 receptors (EPs), EP4 mRNA was predominantly expressed in isolated osteoclasts, whereas the other types of EP mRNA were detected
in only small amounts. These results suggest that the PGE2 inhibitory effect was mediated by an adenylate cyclase system coupled with EP4. This possible association of PGE2 with EP4 in mature osteoclasts was supported by the finding that a specific agonist of EP4 (AE-604) inhibited the bone-resorbing
activity and elevated the intracellular cAMP content. However, butaprost, a selective EP2 agonist, also mimicked the PGE2 effects on isolated osteoclasts although EP2 mRNA expression was minimal. In conclusion, PGE2 directly inhibits bone-resorbing activity of functionally mature osteoclasts by activation of the adenylate cyclase system,
perhaps mainly through EP4.
Received: 21 July 1999 / Accepted: 31 January 2000 相似文献
932.
933.
针刺对实验性变态反应性神经炎TNF-α和IL-4的影响 总被引:2,自引:0,他引:2
目的 探讨肿瘤坏死因子-α(TNF-α)和白细胞介素-4(IL-4)与实验性变态反应性神经炎(EAN)发病的关系,从细胞因子水平研究针刺疗法对本病的免疫调节作用。方法 40只大鼠分为正常对照组、模型组、针刺组、药物组,建立大鼠EAN动物模型,观察大鼠发病率及致病程度,针刺组取腰。夹脊、足三里、悬钟穴,药物组用泼尼松灌胃给药。采用双抗体夹心ELISA法,检测大鼠血清的TNF-αa和IL-4的含量变化。结果 模型组TNF-α含量较正常组明显升高。针刺组和药物组均能降低TNF-α的含量,使其水平接近正常,尤以药物组抑制作用明显。IL-4的含量各组间均无明显差异。结论 提示本病存在Th1/Th2细胞因子间的失衡,其中以Th1型细胞占优势。针刺主要是通过抑制TNF-α等Th1细胞,来重建细胞因子间的平衡。 相似文献
934.
Abstract: There is evidence to indicate that opioid compounds with mixed μ agonist/δ antagonist properties are analgesics with low propensity to produce tolerance and physical dependence. A chimeric peptide containing the potent and selective μ agonist H‐Dmt‐D‐Arg‐Phe‐Lys‐NH2 ([Dmt1]DALDA) (Dmt = 2′,6′‐dimethyltyrosine) and the potent and selective δ antagonist H‐Tyr‐TicΨ[CH2‐NH]Cha‐Phe‐OH (TICP[Ψ]) (Cha = cyclohexylalanine), connected ‘tail‐to‐tail’ via a short linker, was synthesized using a combination of solid‐phase and solution techniques. The resulting peptide, H‐Dmt→D‐Arg→Phe→Lys‐NH‐CH2‐CH2‐NH‐Phe←Cha[NH‐CH2]ΨTic←Tyr‐H, showed the expected μ agonist/δ antagonist profile in the guinea‐pig ileum and mouse vas deferens assays. Its μ and δ receptor binding affinities were in the low nanomolar range, as determined in rat brain membrane binding assays. 相似文献
935.
H. Lboutounne Y. C. Guillaume L. Michel S. Makki Ph. Humbert J. Millet 《Drug development research》2004,61(2):86-94
Trimethylpsoralen (TMP) is often used to treat skin diseases (i.e., psoriasis, vitiligo, etc.). This drug permeates moderately the skin barrier. In the present study, we investigated the effect of formulation on the improvement of TMP skin bioavailability. Three formulations were performed. Each form (liposomes, nanospheres, and EtOH solution) contained 0.05% of TMP. For each preparation, the quantity deposited on the skin surface was 250 µg (Q0). The TMP percutaneous penetration through ex‐vivo human skin was processed by Franz® cells (n=4) using a human albumin solution (1.4% w/v) as receiver medium. The percentages of the extracted TMP that permeated through the skin and that were retained in the skin over 24 h, were calculated with respect to Q0. The values obtained were reported, respectively, as follows: EtOH solution (1.33 vs. 0.08%), liposomes (0.93 vs. 0.93%), and PLG‐nanospheres (0.79 vs. 3.01%). So, considering the correlation between the cumulated amounts of TMP permeated through the skin and the TMP stocked in the skin, the nanosphere form showed the higher quantity of TMP accumulated in the skin structures. On the other hand, the maximum value of the flux (ng/cm2/h) in the steady state of TMP incorporated in each formulation was at 6 h for all formulations: 173.5±1.06 (EtOH solution) > 120.4±1.06 (liposomes) > 93.82±0.88 (PLG‐nanospheres). These results indicate that the controlled release of TMP by incorporation in PLG‐nanospheres may increase drug content in the skin, while maintaining a minimal percutaneous absorption. Finally, this work shows that the PLG‐nanospheres could constitute a promising approach for controlling TMP release in order to maintain its topical activity. Drug Dev. Res. 61:86–94, 2004. © 2004 Wiley‐Liss, Inc. 相似文献
936.
鼻咽癌面颈联合野放疗对唾液腺功能影响的临床分析 总被引:1,自引:0,他引:1
目的 :利用放射性核素99mTcO4-动态显像唾液腺定量测定鼻咽癌面颈联合野放疗前、中、后唾液腺功能的变化并探讨与放疗剂量之间的关系。方法 :2 0 0 3年 2月 1日~ 2 0 0 3年 10月 3 1日 ,分别对 2 0例鼻咽癌面颈联合野放疗患者于放疗前、放疗至 10、3 6~ 40、70Gy时进行99mTcO4-动态显像定量测定其唾液腺(腮腺、颌下腺 )摄锝率 (UR)、泌锝率 (ER)变化 ,同时观察其口干程度进行临床分级。结果 :2 0例鼻咽癌面颈联合野放疗剂量为 10和3 6~ 40Gy时 ,其泌锝率明显低于放疗前 ,P <0 0 5 ,在放疗 70Gy时降到最低 ,P <0 0 1。与临床观察到的口干严重程度一致 ,而其摄锝率在 3 6~ 40Gy照射以前变化不明显 ,无统计学意义。结论 :鼻咽癌面颈联合野照射患者放疗前无明显唾液腺功能障碍 ,随着放疗剂量的增加 ,唾液腺功能明显下降 ,其ER较UR下降明显 ,在确保患者放疗疗效的同时 ,应尽可能提高放疗技术 ,减少唾液腺照射剂量和放疗体积 ,保护唾液腺功能 ,以提高患者的生活质量。 相似文献
937.
肺癌患者外周血T淋巴细胞亚群检测的临床研究 总被引:6,自引:0,他引:6
通过流式细胞仪对确诊原发性支气管肺癌患者外周血T淋巴细胞亚群检测研究 ,并与健康人作对比。结果显示 ,肺癌患者CD3 ( 68 88± 11 80 )和CD4 ( 3 8 83± 10 3 0 )以及CD4 /CD8 ( 1 5 3± 0 74)比例均比正常人 ( 74 2 1±5 5 1,43 92± 7 0 2 ,1 89± 0 5 4)下降 ,CD8 ( 2 9 2 6± 10 5 8)高于正常人 ( 2 4 5 7± 6 3 5 ) ,两组之间差异有统计学意义 ,P均 <0 0 5。肿瘤临床分期之间检测结果差异无统计学意义 ,而病理类型中未分化癌与鳞癌之间CD4 和CD4 /CD8 下降具有统计学意义。初步研究结果提示 ,原发性支气管肺癌患者存在细胞免疫功能低下 ,并与细胞分化类型有关。 相似文献
938.
二乙酰去水卫矛醇联合p53基因转染对肝癌细胞生长的影响 总被引:3,自引:0,他引:3
目的:观察野生型p53基因转染联合二乙酰去水卫矛醇(1,2:5,6-dianhydro-3,4-(liacetylgalactitol,DADAG)对肝癌细胞生长的影响。方法:将克隆有野生型p53基因的pUHD10-3质粒,通过脂质体(lipofectamine)介导转染人肝癌细胞,同时,在培养液中加入DADAG,用四甲基偶氮唑(MTT)法分析细胞的生长情况。结果:人肝癌细胞HLE转染野生型p53基因后,其生长作用明显受到抑制,细胞生长抑制率在第4天可达67.68%。如果HLE细胞中只加入含DADAG的培养液后,其细胞生长也受到一定的抑制,生长抑制率最高可达到53.09%。肝癌细胞HLE转染野生型p53基因后联合应用DADAG时,细胞的生长抑制率在第4天可达到85.37%,实验结果显示DAD-AG联合野生型p53基因增强对肝癌细胞的生长抑制作用。结论:DADAG能加强野生型p53基因对肝癌细胞的生长抑制作用。 相似文献
939.
EB病毒(EBV)是一种DNA肿瘤病毒,以往有关EBV致瘤机制的研究主要集中在B淋巴细胞.日前检测发现人类T细胞淋巴瘤也存在EBV感染.近年来研究表明EBV感染可转化T淋巴细胞,EBV可能在T细胞淋巴瘤的发生中起重要作用.观察LMP1在T细胞中的分子生物效应,有助于了解T淋巴细胞中EBV的感染途径、感染方式以及T细胞淋巴瘤的发生机制. 相似文献
940.
Purpose To observe therapeutic effect of electroacupuncture Neixiyan (Ex-LE 4) and Dubi (ST 35) in treating osteoarthritis of knee
joint.Method All the 120 cases were randomly divided into electroacupuncture and control groups, 60 cases in each group, and they were
given electroacupuncture and Ritalin slowreleased tablet respectively, and pain, mobility and swelling degree of knee joint
were observed before and after treatments.Results In treatment group, the average score increased by 18, while in control group, it increased by 12.33 (P<0.05) after treatment.Conclusion Therapeutic effect of electroacupuncture Neixiyan (Ex-LE 4) and Dubi (ST 35) in treating osteoarthritis of knee joint was
better than that of administration of Ritalin slow-released tablet.
Author: DAI Qi-ping (1966-), female, attending physician
Translator: Wu Xue-fei 相似文献